Active Ingredient: EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201806
Product Number: 001
Approval Date: Oct 7, 2021
Applicant Holder Full Name: HETERO LABS LTD UNIT III
Marketing Status:
Prescription
Patent and Exclusivity Information